Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation

Leukemia. 2016 Oct;30(10):2086-2089. doi: 10.1038/leu.2016.125. Epub 2016 May 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Blood Transfusion*
  • Bone Marrow Transplantation*
  • Cyclophosphamide / therapeutic use*
  • Europe
  • Haplotypes*
  • Humans
  • Lymphoma, Non-Hodgkin / therapy*
  • Registries*
  • Siblings*
  • Survival Analysis

Substances

  • Antineoplastic Agents, Alkylating
  • Cyclophosphamide